U.S. Over-the-Counter Diagnostic Testing Market to Catapult to $10.19 Billion by 2018
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 10/09/12 -- TriMarkPublications.com cites in its newly published "Over-the-Counter Diagnostic Products World Markets" report that the U.S. over-the-counter market will catapult to $10.19 billion by 2018. For more information, visit: .
The over-the-counter market can be categorized into two main modalities: home testing (where products are purchased at pharmacies and drug stores) and decentralized testing in non-institutional settings (insurance companies and law enforcement agencies). Within these modalities, there are many types of over-the-counter , including tests for glucose monitoring, pregnancy, drugs of abuse screening, infectious disease, hepatitis, HIV, coagulation and fertility. A worldwide growth rate of approximately 10.4% is projected for over-the-counter between 2011 and 2018.
The "Over-the-Counter Diagnostic Products World Markets" report covers:
In-Home HIV Testing
Coagulation Testing
Urine Dipstick Testing
Fertility Testing
In-Home DNA Analysis
Biowarfare Detection
Home Patient Monitoring Devices
Home Patient Alert Systems
Home Genetic Testing Kits
Home Paternity Testing
Health Hazards Detection
Colorectal Cancer (Occult Blood) Testing
Alzheimer's Disease Home Screening Test
Tobacco Testing
Cholesterol Testing
Immunoassay Technology
Biosensor Technology
Home Telemedicine Devices
Insulin Pumps
The "Over-the-Counter Diagnostic Products World Markets" report examines companies manufacturing over-the-counter equipment and supplies in the world. Companies covered include: A Menarini, Abbott, ACON, AgaMatrix, Alere, American Bio Medica, AmeriSourceBergen, Ani Biotech, ARKRAY, Bayer, Becton Dickinson, Biomerica, Calypte, Cardinal, HemoCue, Home Access, Insulet, International Technidyne Nexus, Johnson & Johnson, LifeScan, NOVA, OraQuick, Orasure, Princeton BioMeditech, Quidel, Roche, Saliva and Trinity Biotech.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: .
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit .
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 09.10.2012 - 17:45 Uhr
Sprache: Deutsch
News-ID 190877
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 207 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"U.S. Over-the-Counter Diagnostic Testing Market to Catapult to $10.19 Billion by 2018"
steht unter der journalistisch-redaktionellen Verantwortung von
TriMarkPublications.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
